| Literature DB >> 32245108 |
Agnieszka Rodzik1,2, Paweł Pomastowski2, Gulyaim N Sagandykova1,2, Bogusław Buszewski1,2.
Abstract
Whey proteins tend to interact with metal ions, which have implications in different fields related to human life quality. There are two impacts of such interactions: they can provide opportunities for applications in food and nutraceuticals, but may lead to analytical challenges related to their study and outcomes for food processing, storage, and food interactions. Moreover, interactions of whey proteins with metal ions are complicated, requiring deep understanding, leading to consequences, such as metalloproteins, metallocomplexes, nanoparticles, or aggregates, creating a biologically active system. To understand the phenomena of metal-protein interactions, it is important to develop analytical approaches combined with studies of changes in the biological activity and to analyze the impact of such interactions on different fields. The aim of this review was to discuss chemistry of β-lactoglobulin, α-lactalbumin, and lactotransferrin, their interactions with different metal ions, analytical techniques used to study them and the implications for food and nutraceuticals.Entities:
Keywords: food safety; food storage; metallocomplexes; metal–protein interactions; nutraceuticals; whey proteins
Mesh:
Substances:
Year: 2020 PMID: 32245108 PMCID: PMC7139725 DOI: 10.3390/ijms21062156
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Structures of whey proteins at high resolution extracted from the protein data bank database; iron atoms are denoted in red color for LTF together with carbonate ions; calcium atom is denoted in green color for α-lactalbumin, PDB codes: LTF—1BIY; α-LA—1HFX; β-LG—6RYT.
Different whey protein molecular weights associated with post-translational modifications (PTMs).
| Protein | Mol. Weight (kDa) | Theoretical mol. Weight (kDa)* | PTM | Method of Isolation/Purification | Identification | Ref. |
|---|---|---|---|---|---|---|
| β-LG | 18 | 18.277 | - | standard of β-LG (protein content > 90%) | SDS-PAGE | [ |
| 18.5 | ||||||
| β-LG | 18.3 | 18.277 | monomeric and the dimeric forms at pH 7.4 glycated β-lactoglobulin | β-LG was dissolved in 9.1 mM glucose in water, and the pH was adjusted to 7 with 50 mM phosphate buffer | MALDI-TOF-MS | [ |
| 36.6 | ||||||
| β-LG | 17.4 | 18.277 | - | anion-exchange chromatography (DEAE-Sepharose) | SDS-PAGE | [ |
| β-LG | 19.9 | 18.277 | proteins appeared as strings of spots, indicating their different isoforms with different charges as a result of PTMs occurring prior to secretion | precipitation via ammonium sulphate fractionation | 2-DE | [ |
| α-LA | 16.2 | 16.247 | MALDI-MS | |||
| α-LA | 14.1 | 16.247 | small mass differences ruled out PTMs, such as phosphorylation and glycosylation | precipitation by ammonium sulphate | MALDI-TOF-MS | [ |
| SA | 67.7 (SA) | 69.367 | glycosylation of specific milk proteins was shown to vary during lactation; no potential N-glycosylation and O-linked glycans (SA), known N-linked glycoprotein (LTF) | 0.5 mL of raw milk was centrifuged at 4 °C for 30 min, fat and cellular layers were removed; residual lipids were removed by addition of three volumes (1.5 mL) of 2:1 chloroform/methanol, agitation, retaining of supernatant; protein was precipitated from supernatant with ethanol overnight at 4 °C, followed by centrifugation; precipitate was re-suspended in 50 mM ammonium bicarbonate buffer (pH 7.5); glycans were separated by SDS-PAGE and extracted for MALDI-MS analysis | MALDI-MS | [ |
| 79.8 (LTF) | ||||||
| LTF | 69.0 (SA) | 78.056 | LC–MS/MS | |||
| 78.0 (LTF) | ||||||
| LTF | 80.002 | 78.056 | - | milk was defatted by centrifugation, and the pH was then adjusted to 4.6 using hydrochloric acid; precipitated casein was removed by centrifugation | RP-LC–MS/MS | [ |
*values of theoretical molecular weight of the proteins from the Uniprot database (bovine, and for SA-human); Uniprot KB: α-LA—P00711; LTF—P24627; SA—P02768, the value for β-LG accounts for form B from publication of Eigel et al. [22].
Figure 2Consequences of metal–protein interactions: (A) metalloproteins, (B) nanoparticles, and (C) metallocomplexes; 2A—carbonate binding site of LTF as a metalloprotein; 2B—formed nanoparticles as a result of interaction of LTF with a metal ion; 2C—metallocomplexes formed by weak electrostatic and sandwich interactions; B and C can form a nanocomposite.
Interactions of metal ions with proteins and their characterization.
| Metal/Conc. | Compound/Conc. | Interaction | Analytical method | Ref. |
|---|---|---|---|---|
| Zn2+ | strong binding affinities: | ITC | [ | |
| LTF | 2.7 × 105 M−1 | |||
| BSA | 2.3 × 105 M−1 | |||
| α-LA | 1.5 × 105 M−1 | |||
| β-LG | 1.5 × 105 M−1 | |||
| Zn2+(6.23 mM) | α-LA (63.9 µM) | two sets of independent binding sites for zinc (II) | ITC | [ |
| two ions bind with the binding constant of 4.53 × 104 M−1 | fluorescence | |||
| four ions bind with the binding constant of 963 M−1 | CD | |||
| electrostatic interactions | DSC | |||
| Zn2+ | whey-derived peptides | zinc chelation | FT-IR | [ |
| electrostatic interactions | zinc chelating capacity | |||
| ZnO | WPI | DSC curves allowed to suggest; hydrogen bonding; O–Zn–O bonding; or electrostatic interactions; XRD and UV-Vis allowed to observe evidence for phase structure and crystal quality of ZnO nanoparticles; TEM—image of ZnO-WPI nanocomposite | XRD, TEM, DSC, UV-Vis | [ |
| Ag+ | LTF | two stages: | MALDI-TOF/TOF-MS, ICP-MS, FT-IR, SERS, TEM, EDX, electrophoretic techniques | [ |
| La (III)-Cys complex | hydrogen bonds, van der Waals interactions | NMR, UV-Vis, FT-IR, TG-DTA, FRET, CD | [ | |
| BSA | KBSA-La 0.11 × 104 M−1; | |||
| β-LG | Kβ-LG-La 0.63 × 103 M−1 | |||
| La (III)-Trp complex | hydrophobic interactions: | NMR, UV-Vis, FT-IR, TG-DTA | [ | |
| HSA | Kb 0.138 × 104 M−1 (303 K) | |||
| La (III)-Phe complex | hydrogen bonds, hydrophobic interactions | NMR, UV-Vis, FT-IR | [ | |
| HSA | ||||
| Pd (II) complex | hydrogen bonds, van der Waals interactions | NMR, UV-Vis, FT-IR | [ | |
| HSA (1 × 105 M) | Kb 0.5 × 104 M−1; | |||
| β-LG (1 × 105 M) | Kb 0.2 × 103 M−1 | |||
| Pd (II) complexes (10−4 M) | hydrogen bonds, van der Waals interactions | NMR, UV-Vis, FT-IR, FRET | [ | |
| HSA (2 mg/mL) | I complex: Kb 0.49 × 104 M−1 (293 K); | |||
| II complex: Kb 0.79 × 104 M−1 (293 K) | ||||
| Co (II)-Ni (II) complexes | hydrogen bonds, van der Waals interactions | UV-Vis, FT-IR, fluorescence | [ | |
| HSA | Kb 3.16 × 106 M−1 (303 K); | |||
| β-LG | Kb 0.54 × 105 M−1 (303 K) | |||
| Mn (II)-Co (II) complexes (5 × 10−3 M) | hydrogen bonds, hydrophobic interactions | UV-Vis, FT-IR, FRET | [ | |
| HSA (5 × 10−4 M) | I: Kb 7.4 ± 0.04 × 104 M−1 (303 K); | |||
| II: Kb 6.08 ± 0.09 × 103 M−1 (303 K) | ||||
| β-LG (5 × 10−4 M) | I: Kb 7.13 ± 0.03 × 104 M−1 (303 K); | |||
| II: Kb 2.62 ± 0.05 × 103 M−1 (303 K) |
Analytical techniques used for the separation and identification of whey proteins.
| Proteins | Matrix | Isolation | Separation | Identification | Ref. |
|---|---|---|---|---|---|
| α-LA | cheese | cheese extracts were desalted and preconcentrated using microcon membranes | CE with fused silica capillaries | DAD | [ |
| β-LG A | |||||
| β-LG B | |||||
| β-LG | cow, goat, and ewe cheeses, incl. those of a single animal origin, binary ternary mixtures | desalted, preconcentrated samples were obtained with microcon membranes | CE with fused silica uncoated capillaries | DAD | [ |
| α-LA | |||||
| α-LA | raw milk | mixture of standards of purified proteins, separation was achieved by adding SEP and TPS buffers to milk | SDS-PAGE; Microfluidic chip electrophoresis | Fluorescence | [ |
| β-LG | |||||
| α-LA | fresh skim milk | mixed protein standards were prepared by combining each of the individual protein solutions (1 mL) | SDS-PAGE; Microfluidic chip electrophoresis | Fluorescence | [ |
| β-LG | |||||
| caseins | |||||
| β-LG | milk | diluting 200 µL of ultracentrifuged whey with 400 µL of HPLC-grade water | LC, Jupiter C4 column; Microchip electrophoresis | UV, MS; Fluorescence | [ |
| α-LA | |||||
| SA | |||||
| LTF | milk | samples were centrifuged to remove fat; skim milk was loaded onto lactoferrin immunoaffinity column | LC, Symmetry C4 Column | PDA | [ |
| β-LG | |||||
| α-LA | |||||
| β-LG | buffalo mozzarella | mixtures of cow’s milk, water buffalo’s milk, mixtures of brine from cow’s milk mozzarella, brine from buffalo mozzarella were prepared in diff. vol. ratios for calibration purposes | LC, Supelco Discovery Bio Wide Pore C8 column | MS | [ |
| α-LA | WPC | standard pure proteins to determine ret. times; equilibration buffer Tris-HCl at 20 mM; elution buffer Tris-HCl at 20 mM with 1 M NaCl were used for separation | Mono Q5/50 GL anion-exchange column, FPLC | UV-Vis; SDS-PAGE | [ |
| β-LG | |||||
| BSA | |||||
| α-LA | mozzarella cheese whey | different equilibration and elution buffers were prepared | Chromatographic column; packed with SP Sepharose Big; Beads cation exchanger, HPLC | UV-Vis; SDS-PAGE | [ |
| β-LG | |||||
| BSA |
Instrumental techniques used to study the metal–protein interactions and their potential applications.
| Compounds | Form | Application | Analytical methods | Ref. |
|---|---|---|---|---|
| LTF | metalloprotein | regulation of inflammation and oxidative stress in vertebrates | AFM | [ |
| α-LA | metalloprotein | nutrition of infants in a long breastfeeding stage | Native-PAGE; SEC-ICP-MS; MALDI-TOF/TOF-MS | [ |
| LF | ||||
| serum albumin | ||||
| LTF | nanoparticles | gene delivery carrier with targeting abilities | TEM | [ |
| WPI | nanoparticles | production of antimicrobial cotton fabrics | UV-Vis; TEM; SEM | [ |
| LTF | nanoparticles | increased therapeutic efficacy of treatment of malignant melanoma | TEM; SEM; DLS; FT-IR | [ |
| LTF | metallocomposites; nanoparticles | in medicine and food industry as an antimicrobial agent | MALDI-TOF/TOF-MS; ICP-MS; FT-IR; SERS; TEM; I-DE; zeta potential measurements | [ |
| LTF | nanoparticles | drug delivery strategy against the neurotoxicity in dopaminergic neurons | FE-SEM; AFM; DLS | [ |
| LTF | metalloprotein | a therapeutic lead for controlling neutrophil extracellular traps (NETs) release in autoimmune and inflammatory diseases | TEM; SEM; fluorescence microscopy; agarose gel electrophoresis | [ |
| IgA | metalloprotein | health and nutrition of breastfed newborns | ESI-MS/MS; FAAS | [ |
| LTF | nanoparticles | target specific drug delivery, encapsulation of the drug | FE-SEM; AFM; FT-IR | [ |
| LTF | nanoparticles | drug delivery for effective targeting therapy of brain glioma | Particle electrophoresis | [ |
| BSA | ||||
| LTF | metalloprotein | antimicrobial biomaterials for dental applications | HPLC; SEM; XPS | [ |
| LTF | metalloprotein | inhibition of the attachment of free HIV-1 to epithelial cells | ELISA; flow cytometry | [ |
| LTF | Metalloprotein; metallocomplex | immobilized DNA effective for LTF purification | HPCEC; HPIMAC; HPLC; HPSEC; SDS-PAGE | [ |